Pinpoint Molecular Ltd are working on a simple blood test for Alzheimer’s Disease.

The figure on the left shows the results of a simple blood test that we have developed using our novel resin extraction technology. Plasma samples from Alzheimer’s Disease patients and normal patients were tested. Our test showed a clear difference when tested on a sensitive platform such as the Fujirebio Lumipulse.

Why do we need a simple blood test?

A test is needed:

  • To ensure early and appropriate treatment
  • To monitor the effect of treatment
  • To help in discovery of new therapies

Further work to be done

  • More samples need to be tested
  • We need to test other diseases such as Parkinson’s Disease

If you would like to help us by getting involved in our study, please email us at